22 Jul Arbor Biotechnologies
Posted at 18:05h
in
Devyn Smith, Ph.D., CEO
Oct. 8 | 4:15pm | FLW Ballroom F
Cambridge, MA
(Private)
Arbor Biotechnologies is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry. We have the unique ability to work backward from disease pathology and choose the optimal editors or combination of editors for the disease in question.
